Hepatitis b drug combo trial halted early – hope for virus control remains
NCT ID NCT00823342
First seen Apr 08, 2026 · Last updated May 24, 2026 · Updated 5 times
Summary
This study compared two hepatitis B medications, clevudine and tenofovir, given alone or together for 96 weeks in adults with chronic hepatitis B who had not been treated before. The goal was to see if the combination could better control the virus and reduce the risk of it coming back after stopping treatment. The trial was terminated early, so results are limited, but the approach aimed at long-term disease management rather than a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HBE NEGATIVE CHRONIC HEPATITIS B are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hôpital Saint Joseph
Marseille, 13285, France
Conditions
Explore the condition pages connected to this study.